Search Ontology:
ChEBI
zilucoplan
- Term ID
- CHEBI:229659
- Synonyms
-
- N-{[(2S,5S,8S,11S,14S,22S)-22-acetamido-11-benzyl-8-(3-carbamimidamidopropyl)-5-(2-carboxyethyl)-3,6,9,12,16,23-hexaoxo-2-(propan-2-yl)-1,4,7,10,13,17-hexaazacyclotricosan-14-yl]carbonyl}-N-methyl-L-alpha-aspartyl-3-methyl-L-valyl-L-tyrosyl-3-(1H-pyrrolo[
- RA 101495
- RA-101495
- RA101495
- RA3193
- zilucoplan
- zilucoplanum
- Definition
- A 15 amino-acid, synthetic macrocyclic peptide with formula C172H278N24O55. Its sodium salt is used for the treatment of generalised myasthenia gravis (a disease that leads to muscle weakness and tiredness) in adults whose immune system produces antibodies against acetylcholine receptors.
- References
-
- CAS:1841136-73-9
- DrugBank:DB15636
- KEGG:D12357
- PMID:32065623
- PMID:33213529
- PMID:33398524
- PMID:33792453
- PMID:35945604
- PMID:36009583
- PMID:36923454
- PMID:37059508
- PMID:37204031
- PMID:37534517
- PMID:37622108
- PMID:37818356
- PMID:37962198
- PMID:38051802
- PMID:38093160
- PMID:38212553
- PMID:38300476
- PMID:38400914
- PMID:38576149
- Wikipedia:Zilucoplan
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Phenotype
Phenotype resulting from zilucoplan
Phenotype where environments contain zilucoplan
Phenotype modified by environments containing zilucoplan
Human Disease Model